Seagen Inc.
GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

Last updated:

Abstract:

The invention provides murine, chimeric, and humanized antibodies that specifically bind to GPC3 and conjugates thereof.

Status:
Application
Type:

Utility

Filling date:

15 Feb 2019

Issue date:

25 Nov 2021